Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
Chenglong Chen, Lu Xie, Tingting Ren, Yi Huang, Jie Xu, Wei Guo
Cancer Letters, 2020
Abstract
An abstract is not available for this record. Please visit the publisher website for more details.
Related Research
- Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma 2013
- Circular RNA circNRIP1 plays oncogenic roles in the progression of osteosarcoma 2021
- A experimental study on chemosensitivity to Osteosarcoma in vitro 2013
- Atypical Cases of Osteosarcoma. 1991
- Diaphyseal osteosarcoma or synchronous osteosarcoma 2020
References
- IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas 2015
- Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma 2014
- Immunotherapeutic Approaches to Sarcoma 2015
- Effect of cytotoxic T-lymphocyte antigen-4, TNF-alpha polymorphisms on osteosarcoma: evidences from a meta-analysis. 2013
- Comprehensive Evaluation of the Cytotoxic T-Lymphocyte Antigen-4 Gene Polymorphisms in Risk of Bone Sarcoma 2014